Teva receives FDA approval for first generic Nexium® delayed-release capsules in U.S.
Teva announced the FDA approval of the first generic equivalent to Nexium (esomeprazole magnesium) Delayed-Release Capsules in the U.S. Nexium Delayed-Release Capsules, marketed by AstraZeneca, had annual sales of approximately $6 billion in the U.S., according to IMS data as of Nov. 2014. January 26, 2015